Arelis Salas, Ph.D.
Affiliations: | 2010 | Medical University of South Carolina, Charleston, SC, United States |
Area:
Molecular BiologyGoogle:
"Arelis Salas"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Besim Ogretmen | grad student | 2010 | MUSC | |
| (Regulation of imatinib-resistance through Ber-Abl stability by SK1/S1P/S1PR signaling in chronic myeloid leukemia (CML).) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Salas A, Ponnusamy S, Senkal CE, et al. (2011) Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A. Blood. 117: 5941-52 |
| Ponnusamy S, Meyers-Needham M, Senkal CE, et al. (2010) Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. Future Oncology (London, England). 6: 1603-24 |
| Baran Y, Salas A, Senkal CE, et al. (2007) Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells. The Journal of Biological Chemistry. 282: 10922-34 |
| Sundararaj KP, Wood RE, Ponnusamy S, et al. (2004) Rapid shortening of telomere length in response to ceramide involves the inhibition of telomere binding activity of nuclear glyceraldehyde-3-phosphate dehydrogenase. The Journal of Biological Chemistry. 279: 6152-62 |